1100023I saic - preclin services - DEV of biopharmaceutical products - task BP-013 manufacture of A12 human anti-poliovirus antibodies - biod can 8470038 $27,584
Ended Awarded Last action
- Contract number
- HHSN27200013
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,154
Award facts
- Contract value 100% obligated
- $23,154.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21703, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Funding Only Action | -$4,430 | |
| Other Administrative Action | $0 | |
| Original award | $27,584 |
Quick answers
Who was awarded contract HHSN27200013?
HHSN27200013 was awarded to Leidos, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 18, 2014.
How much is contract HHSN27200013 worth?
The government has obligated $23,154 on HHSN27200013.
Is contract HHSN27200013 an order under another contract?
Yes. HHSN27200013 is a delivery order under HHSN272201100023I, an indefinite delivery contract.
Was contract HHSN27200013 competed?
The extent of competition for HHSN27200013 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award